Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Comparison of tuberculosis infection rates in a national database of renal transplant patients with data from a single center in Taiwan.

Chen CH, Wu MJ, Lin CH, Chang SN, Wen MC, Cheng CH, Yu TM, Chuang YW, Huang ST, Tsai SF, Lo YC, Shu KH.

Transplant Proc. 2014;46(2):588-91. doi: 10.1016/j.transproceed.2013.12.024.

PMID:
24656019
2.

A nationwide population-based study of the risk of tuberculosis in different solid organ transplantations in Taiwan.

Chen CH, Shu KH, Ho HC, Cheng SB, Lin CC, Wei HJ, Lin CH, Chang SN, Wu MJ.

Transplant Proc. 2014 May;46(4):1032-5. doi: 10.1016/j.transproceed.2013.10.051.

PMID:
24815120
3.

Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.

Agarwal SK, Bhowmik D, Mahajan S, Bagchi S.

Transpl Infect Dis. 2017 Feb;19(1). doi: 10.1111/tid.12626. Epub 2016 Dec 16.

PMID:
27775825
4.

Mycobacterium tuberculosis infection following renal transplantation in Taiwan.

Chen CH, Lian JD, Cheng CH, Wu MJ, Lee WC, Shu KH.

Transpl Infect Dis. 2006 Sep;8(3):148-56.

PMID:
16913973
5.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960
6.

Impact of pulmonary and extrapulmonary tuberculosis infection in kidney transplantation: a nationwide population-based study in Taiwan.

Ou SM, Liu CJ, Teng CJ, Lin YT, Chang YS, Chiang SC, Tzeng CH, Chen TJ.

Transpl Infect Dis. 2012 Oct;14(5):502-9. doi: 10.1111/j.1399-3062.2012.00737.x. Epub 2012 May 10.

PMID:
22571347
7.

Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.

Favi E, Citterio F, Spagnoletti G, Gargiulo A, Delreno F, Romagnoli J, Castagneto M.

Transplant Proc. 2009 May;41(4):1152-5. doi: 10.1016/j.transproceed.2009.03.019.

PMID:
19460503
8.

Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.

Bakr MA, Gheith OA, Ismael AM, Baz ME, Shehab El-Dein AB, Ghoneim MA.

Exp Clin Transplant. 2008 Mar;6(1):48-53.

9.

Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results.

Chamienia A, Dębska-Ślizień A, Król E, Biedunkiewicz B, Rutkowski B.

Transplant Proc. 2014 Oct;46(8):2714-8. doi: 10.1016/j.transproceed.2014.09.045.

PMID:
25380901
10.

Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.

Neu AM, Ho PL, Fine RN, Furth SL, Fivush BA.

Pediatr Transplant. 2003 Jun;7(3):217-22.

PMID:
12756047
11.

Mycophenolate mofetil in pancreas transplantation.

Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC.

Transplantation. 1998 Aug 15;66(3):318-23.

PMID:
9721799
12.
13.

Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids.

Cristelli MP, Tedesco-Silva H, Medina-Pestana JO, Franco MF.

Transpl Infect Dis. 2013 Aug;15(4):369-78. doi: 10.1111/tid.12095. Epub 2013 May 22.

PMID:
23701592
14.
15.

Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.

Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I.

Transplantation. 1997 Dec 27;64(12):1695-700.

PMID:
9422404
16.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

17.

Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.

Zuckermann A, Reichenspurner H, Birsan T, Treede H, Deviatko E, Reichart B, Klepetko W.

J Thorac Cardiovasc Surg. 2003 Apr;125(4):891-900.

PMID:
12698153
19.

Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.

de Winter BC, Mathot RA, Sombogaard F, Neumann I, van Hest RM, Doorduijn JK, van Gelder T.

Ther Drug Monit. 2010 Oct;32(5):606-14. doi: 10.1097/FTD.0b013e3181efd715.

PMID:
20720518
20.

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I.

Transplantation. 1997 Dec 27;64(12):1755-60.

PMID:
9422416

Supplemental Content

Support Center